Opendata, web and dolomites

iMOTED SIGNED

iMOTED Platform Built to improve Clinical Trial outcomes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iMOTED project word cloud

Explore the words cloud of the iMOTED project. It provides you a very rough idea of what is the project "iMOTED" about.

launching    13    ec    customizable    point    countries    simplify       day    collected    spend    reduce    trials    drug    trial    marketed    clinical    time    2022    amount    intuitive    predictions    business    therapy    platform    sources    breakeven    licenses    imoted    costing    individuals    tested    industry    data    designed    economic    market    safe    body    12    80    delayed    huge    delay    losses    roi    employing    perform    give    marketing    carg    560    human    ct    exceed    sponsors    investigators    cumulative    registered    opportunity    return    clinic    companies    140    forecasted    revenues    inefficient    bn    2024    whom    launch    2017    pharma    drugs    considering    period    prove    device    quality    upwards    interface    software    multiple    simulations    generation    turnover    asking    start    120    stage    complexity    usually    selling    beginning    hence    estimations    near    rate    domestic    believe    belongs    alarms    31    feasibility    initially   

Project "iMOTED" data sheet

The following table provides information about the project.

Coordinator
BIODATUP SL 

Organization address
address: PASEO MIKELETEGUI 83
city: SAN SEBASTIAN DONOSTIA
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://biodatup.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIODATUP SL ES (SAN SEBASTIAN DONOSTIA) coordinator 50˙000.00

Map

 Project objective

Clinical Trials (CT) are designed to prove if a drug, device or therapy is safe and effective in the human body, so they are already tested in individuals. The CT investigators and sponsors spend great amount of resources on data management and project and data quality control. In 2017 more than 120,000 CT have been registered, of which near 31,000 are carried out in the EU. Usually the average duration of CT from start to marketing is 7.5 years, however, more than 80% of CT are delayed from 1 to 6 month costing to the companies upwards of 30,000 € per day per trial. In most of the cases, this delay is due to inefficient management systems. With CT conducted in over 140 countries, the complexity and rate of change in trials is increasing. Considering this huge business opportunity, we have been working in a customizable software system to manage and simplify CT development. iMOTED platform will ensure high quality data, collected from multiple sources by using real time analysis of data, a simple and intuitive interface, generation of real time alarms employing estimations, predictions & simulations In this way, we expect to reduce the economic losses that pharma industry has when launching a new drug, for whom only 2 out of 10 marketed drugs return revenues that exceed R&D costs. iMOTED belongs to the e-clinic market, which is forecasted to reach €7.6 Bn by 2022 growing at a CARG of 12.4% over the period 2017-2022. We will initially target Europe as our domestic market, to start selling the IMOTED licenses. We expect to have our breakeven point two years after the beginning of the project, a cumulative turnover of €13 M by 2022, that will give us a ROI of 560% in 2024. Hence, at this stage of development we believe that we need to perform a through feasibility study to assess for the challenges and tasks that we still must accomplish to launch iMOTED for what we are asking for EC support.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMOTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMOTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

Path Feel (2019)

Insoles for Neuropathy and Balance Issues

Read More